Thailand

BMI View: Despite the downgrade of the pharmaceutical market forecast for Thailand, we continue to maintain that the country will see stable pharmaceutical sales growth. This is primarily... 2012-02-09

BMI View: Thailand's medical device sector will be boosted by the government's continued effort to promote medical tourism, as well as the increasingly ageing population that will... 2011-10-25

BMI View: In countries with under-developed healthcare systems, the presence of non-governmental organisations (NGOs) providing medical aid is essential. Government efforts to improve... 2011-10-06

BMI View: Thailand will remain attractive to bold investors according to its score in our proprietary pharmaceuticals and healthcare Business Environment Ratings (BERs). In addition... 2011-07-14

BMI View: Attention deficit hyperactivity disorder (ADHD) represents a small but growing opportunity for pharmaceutical companies operating in South East Asia. The prevalence of the... 2011-05-04

BMI View: Thailand's THB127bn (US$3.96bn) pharmaceutical market represents a moderate proposition to multinational pharmaceutical companies. Although projected growth is robust (five-year... 2011-02-22

BMI View: Asia Pacific's attractiveness to multinational drugmakers is faltering. BMI's Pharmaceuticals & Healthcare Business Environment Ratings (BERs), which assess countries... 2011-01-14

BMI View: Thailand's liberal pharmaceutical pricing regime is in need of reform. The current framework favours the interests of drugmakers over patient welfare, which is leading to... 2011-01-12

Developed state underperformance remains a recurring theme within our Industry analysis. We remain concerned about US labour market weakness and its impact, particularly on consumer... 2010-09-28

BMI View: Thailand's US$3.76bn pharmaceutical market is characterised by modest rewards and significant risks. Despite a booming economy, medicines sales have been constrained by the... 2010-09-24